30 Day Trial

Bone Biologics Signs Option to License Nell-1 Bone Growth Factor for Use in Osteoporosis

Share:

Bone Biologics signed an option agreement with UCLA for an opportunity to exclusively license the use of Nell-1 bone growth factor in the treatment of osteoporosis.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.